Use of 50/50 Premixed Insulin Analogs in Type 2 Diabetes: Systematic Review and Clinical Recommendations.

about

Use of 50/50 Premixed Insulin Analogs in Type 2 Diabetes: Systematic Review and Clinical Recommendations.

Item

http://www.wikidata.org/entity/Q50108204

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Use of 50/50 Premixed Insulin ...... and Clinical Recommendations.

@en

Use of 50/50 Premixed Insulin ...... and Clinical Recommendations.

@nl

type

Item

label

Use of 50/50 Premixed Insulin ...... and Clinical Recommendations.

@en

Use of 50/50 Premixed Insulin ...... and Clinical Recommendations.

@nl

prefLabel

Use of 50/50 Premixed Insulin ...... and Clinical Recommendations.

@en

Use of 50/50 Premixed Insulin ...... and Clinical Recommendations.

@nl

P1476

Use of 50/50 Premixed Insulin ...... and Clinical Recommendations.

@en

P2093

Gary Deed

http://www.w3.org/2001/XMLSchema#string

Gary Kilov

http://www.w3.org/2001/XMLSchema#string

Jane Overland

http://www.w3.org/2001/XMLSchema#string

Richard Cutfield

http://www.w3.org/2001/XMLSchema#string

Ted Wu

http://www.w3.org/2001/XMLSchema#string

Trisha Dunning

http://www.w3.org/2001/XMLSchema#string

P2860

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

Comparison of thrice-daily lispro 50/50 vs thrice-daily lispro in combination with sulfonylurea as initial insulin therapy for type 2 diabetes

Effects of twice-daily injections of premixed insulin analog on glycemic control in type 2 diabetic patients

Prandial-basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia: initiate and progressively advance insulin therapy in type 2 diabetes

A Randomized Trial of Step-up Treatment with Premixed Insulin Lispro-50/50 vs. Aspart-70/30 in Patients with Type 2 Diabetes Mellitus.

Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes

Intensifying existing premix therapy (BIAsp 30) with BIAsp 50 and BIAsp 70: A consensus statement.

Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes

P2888

s13300-017-0328-6

P304

1265-1296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13300-017-0328-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29116584

http://www.w3.org/2001/XMLSchema#string

P932

5688993

http://www.w3.org/2001/XMLSchema#string